Davis Polk Guides Roche On $7.1B Deal For US Drugmaker
Swiss health care company Roche said Monday that it will buy Telavant Holdings Inc., a U.S. drugmaker, from rivals Roivant and Pfizer for $7.1 billion in a move that will give it...To view the full article, register now.
Already a subscriber? Click here to view full article